Our report of IVUS guided stenting of HeartMate 3 extrinsic outflow graft obstruction (EOGO) in @JACCJournals Interventions. How often are you seeing these cases? Are you screening all HM3 patients with CTAs? How are you treating these patients? https://t.co/KqngAcOD9K
@sciqst@g_giustinoMD@CraigBasman This is rare - my first experience of losing a wire in >1000 sapien valves. But we took a team approach to solving the problem and found this creative solution. Glad we could share and hope it is helpful to the #TAVR community.
Great technique to bail-out lost wire position in the LV during balloon-expandable TAVR using a 4-8 mm EN-snare through the delivery system. Nice! @ryankaple@CraigBasman
A Microsnare Technique for Transcatheter Heart Valve Recrossing After Inadvertent Wire Withdrawal From Left Ventricle | JACC: Cardiovascular Interventions https://t.co/utIUk83eT0
Join us for our Advances in Cardiovascular Symposium on Wednesday, Sept 25, from 5:00 - 8:00 pm. Registration is free (in person or virtual). We will review ablation for AFib, updates in CTO interventions, and percutaneous tricsupid valve interventions https://t.co/0hv9yzcJy0
A long-waited PREVENT trial is now presented at LBCT-V #ACC2024
🇰🇷From the inception of trial to completion of trial took a decade.
✅1,606 pts with intracoronary imaging-detected “Vulnerable Plaque” randomized 1:1 to (1) Preventive PCI vs (2) OMT alone.
✅Prevent PCI significantly reduce primary composite endpoint (CV death, TV-MI, TVR, hospitalization for UA) at 2 yr. The effect of Preventive PCI was sustained up to 7 years.
✅First RCT shows that Preventive PCI is effective for non-flow limiting vulnerable atherosclerosis coronary plaque.
✅We believe that PREVENT would be one of the seminal investigations in the history of PCI.
@dukwoo_park@GreggWStone@JungMinAhn5@DFCapodanno@djc795@TheLancet
Further details:
https://t.co/R2NJ0dsdML
My conclusion is:
TAVI (whoppingly) superior to SAVR at 1 year in this trial where the heart team decided on type of transcatheter heart valve for their patient.
@djc795@vonBardelebenRS @MattiAdam_MD @PhilippLurz
Structural Case of the Week;
35 y/o M with rheumatic MS (Mean MV gradient 15) for PMBV.
Intracardiac echo guidance with 9Fr Philips 3D ICE.
MVA 0.9 -> 2.2. MV gradient 15mmHg-> 3mmHg
@HMHNewJersey@Philips@ryankaple#Structuralheart#TAVR#Mitral